1. Introduction {#sec0005}
===============

Coronaviruses (CoVs) includes four genera, *alpha*-, *beta*-, *gamma*-, and *deltacoronavirus*, which have been clustered in the *Coronavirinae* subfamily ([@bib0055], [@bib0130]). Coronaviruses (CoVs) are pleomorphic, enveloped viruses ([@bib0125]). Transmissible gastroenteritis virus (TGEV) is a representative CoV in the *alphacoronavirus* genus; severe acute respiratory syndrome-related coronavirus (SARS-related CoV) is a representative of the *betacoronavirus* genus; infectious bronchitis virus (IBV) is a representative of the *gammacoronavirus* genus; and Bulbul-CoV is a representative of the *deltacoronavirus* genus ([@bib0055]). TGEV is positive RNA viruses, which is a large family of enveloped virus ([@bib0110]). The infection of TGEV causes severe diarrhea in suckling piglets (about 2 weeks old), which results in enormous economic loss in swine-producing areas in the world ([@bib0100], [@bib0145]). TGEV genome (28.5 kb) encodes the replicase gene (rep) at the 5′ end and encodes other viral genes at the 3′ end (5′-S-3a-3b-E-M-N-7-3′)([@bib0120]). TGEV genome encodes four structural proteins: spike (S), membrane (M), minor envelope (E), and nucleocapsid (N).

CoVs N proteins are highly basic with a molecular mass ranging from 40 to 63 kDa, depending on the species and strains. N protein binds to the RNA genome, forming a helical nucleocapsid ([@bib0070], [@bib0155]). N protein has a structural role in coronavirus assembly ([@bib0135]) and is a growing evidence for a role in RNA synthesis ([@bib0005], [@bib0010], [@bib0150]). Some reports have been studied the response of host cell to TGEV ([@bib0060], [@bib0180]). Howerer, there is few report about the interaction of N protein with host cell.

Elongation factor 1-alpha (EF1A) is a major translation factor involved in protein synthesis in mammalian cells. EF1A is an abundant G protein that delivers aminoacyl-tRNA to the elongating ribosome ([@bib0030]). EF1A hydrolyzes GTP, dissociates from the aminoacyl-tRNA, and leaves the ribosome ([@bib0115]). Except a major translation factor, EF1A plays important multifunctional roles in mammalian cells. EF1A Interacts with newly synthesized polypeptides for quality surveillance ([@bib0085]). In ubiquitin-dependent degradation, EF1A interacted with ubiquitinated proteins and is essential for ubiquitin-dependent degradation ([@bib0035], [@bib0075]). EF1A undergoes several post-translational modifications, mainly phosphorylation and methylation, and plays important role in facilitating apoptosis ([@bib0105]).

Recently, some reports showed that EF1A interacted with viral proteins. The interaction between EF1A and N protein of SARS-CoV was founded ([@bib0185]). There is no report about whether EF1A interacted with N protein of TGEV. In this study, we demonstrate that EF1A associates with N protein of TGEV and plays a role in virus replication. This study will provide protein-related information for underlying mechanism of coronavirus replication.

2. Materials and methods {#sec0010}
========================

2.1. Cells and virus {#sec0015}
--------------------

Swine testes (ST) cells were obtained from ATCC. ST cells were grown in RPMI-1640 medium supplemented with 10% fetal calf serum under standard culture conditions (5% CO~2~, 37 °C). TGEV infectious strain H (Accession No. [FJ755618](ncbi-n:FJ755618){#intr0005}) and TGEV attenuated strain H (Accession No. [EU074218](ncbi-n:EU074218){#intr0010}) were propagated on an ST cell monolayer ([@bib0175]). Pathogenicity of the TGEV infectious strain H is stronger than TGEV attenuated strain H. However, the attenuated TGEV virus was better to adapt ST cells than infectious TGEV.

2.2. Antibodies {#sec0020}
---------------

Mouse monoclonal antibody (mAb) to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (ab9484) and rabbit polyclonal antibody (pAb) to EF1A (ab140632) were purchased from Abcam. FITC-labeled goat anti-mouse IgG was purchased from Kirkegaard and Perry Laboratories (KPL). TRITC-labeled goat anti-rabbit IgG was purchased from Sigma mAb to N protein of TGEV was prepared in our lab.

2.3. Cell infection {#sec0025}
-------------------

ST cells were infected with TGEV infectious strain H or TGEV attenuated strain H at a multiplicity of infection (MOI) of 1. After adsorption for 1 h, cells were washed and incubated in fresh RPMI-1640 until required post inoculation (hpi).

2.4. Construction of recombinant expression plasmid {#sec0030}
---------------------------------------------------

N gene of TGEV was amplified with primers F-TGEV-N (5′-CAGGATCCGCCAACCAGGGACAACGT-3′) and R-TGEV-N 5′-CACTCGAGGTTCGTTACCTCATCAATCA-3′) containing *Bam* HI and *Xho* I enzyme sites. PCR products were subcloned into a prokaryotic expression pGEX-6p-1 vector (GE Healthcare). Recombinant expression plasmid was designated as pGEX-TGEV-N and confirmed by DNA sequencing.

2.5. GST pull-down assay {#sec0035}
------------------------

GST-N protein was expressed in *Escherichia coli* BL21 (DE3) under induction of 1 mM isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside. GST-N fusion protein was immobilized on beads at 4 °C for 2 h. The lysate of ST cells was prepared using 1 mL RIPA lysis buffer (50 mM Tris--HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, and 1% Triton X-100) containing a protease inhibitor phenylmethanesulfonyl fluoride (PMSF; 1 mM). After centrifugation at 12,000 ×  *g* for 15 min, cell lysate (500 μg) was incubated with the GST-N protein preparation at 4 °C overnight. After washing four times with buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.05% NP-40), the isolated pull-down proteins were then analyzed by 12% PAGE analysis. Expressed GST protein was used as a control.

2.6. Co-immunoprecipitation (Co-IP) assay {#sec0040}
-----------------------------------------

The lysate of ST cells infected with TGEV for 24 h was prepared with RIPA lysis buffer (50 mM Tris--HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.25% deoxycholate) containing a protease inhibitor phenylmethanesulfonyl fluoride (PMSF) (1 mM). After centrifugation at 12,000 ×  *g* for 15 min, lysate supernatant was pretreated with protein A/G plus-agarose (Beyotime) for 30 min at 4 °C to eliminate non-specific binding to the agarose beads. The lysate supernatant (500 μg) was incubated with 1 μg of rabbit pAb to EF1A for overnight at 4 °C. Then, 20 μL resuspended Protein A/G PLUS-Agarose was added to this mixture and incubated at 4 °C on a rocker platform for 2 h. After washing four times with lysis buffer, the isolated immunoprecipitated proteins were then analyzed by western blotting using mAb to N protein of TGEV and rabbit pAb to EF1A. The lysate of TGEV mock-infected ST cells was used as a control.

2.7. Western blotting {#sec0045}
---------------------

Equivalent amounts of cell lysates were subjected to 12% PAGE and then transferred to 0.22 μm nitrocellulose membranes (Hybond-C Extra, Amersham Biosciences). After blotting, the membranes were incubated with rabbit pAb to EF1A for 1 h. After washing three times with PBST, the membranes were inoculated with HRP-conjugated goat anti-rabbit IgG (Sigma) at 37 °C for 1 h and visualized using 3,3′,5,5′-tetramethylbenzidine-stabilized substrate (TMB, Amresco).

2.8. Immunofluorescence assay {#sec0050}
-----------------------------

ST cells inoculated with TGEV were cultured for 24 h. The cells were washed twice with PBS and fixed with paraformaldehyde (4%) for 30 min at 4 °C, and then allowed to air dry. After blotting with 5% skimmed milk powder, the fixed cells were incubated with mAb to TGEV N protein (1:100) and rabbit pAb to EF1A (1:50) for 1 h at 37 °C in a humidified chamber. After washing three times with PBST, the fixed cells were incubated with FITC-labeled goat anti-mouse IgG (1:100, KPL) and TRITC-labeled goat anti-rabbit IgG (1:200, Sigma). The additional nuclear staining with 4′,6-diamidino-2-phenylindole (DAPI, Sigma) was performed as described previously ([@bib0095]). The triple-stained cells were washed three times with PBST and subsequently examined under a Leica TCS SP5 laser confocal microscopy.

2.9. Transfection of siRNA against EF1A {#sec0055}
---------------------------------------

siRNA against EF1A (GenePharma) was used for transfection. The sequence of the siRNA strands was as follows: 5′-GUGGUAUUACCAUUGACAUTT-3′ (sense) and 5′-AUGUCAAUGGUAAUAACCACTT-3′ (antisense). Transfection with siRNA was performed with X-tremeGENE siRNA reagent (Roche) by following the manufacturer\'s instructions. ST cells were cultured overnight in six-well tissue culture plates. The siRNA (20 nM) was complexed with X-tremeGENE siRNA reagent by incubating together at room temperature for 30 min. After removing the cell culture supernatant, the complex was added for incubation 36 h.

2.10. Virus titer assay {#sec0060}
-----------------------

ST cells were re-plated 1 day before infection in 96 well plates for the 50% infectious dose (TCID~50~) assays. Treated samples and their paired controls were thawed as described and immediately serially diluted. Cell cultures were then infected for 1 h. After 48 h of incubation, CPE was observed. TCID~50~ is calculated using the method of Reed and Munch. Virus titer assay were performed three times for each condition and were performed using the Student\'s *t*-test.

3. Results {#sec0065}
==========

3.1. Expression and purification of TGEV N protein {#sec0100}
--------------------------------------------------

Full-length TGEV N protein with a GST tag was expressed in E. coli BL21 (DE3) using a T7 polymerase expression system. GST-N protein was successfully expressed and purified in BL21 (DE3) in soluble fractions ([Fig. 1](#fig0005){ref-type="fig"} ). Western blot analysis for detection of the GST tag confirmed expression of an ∼70-kDa recombinant GST-N protein ([Fig. 1](#fig0005){ref-type="fig"}). Purified full-length recombinant GST-N protein was used in subsequent experiments.Fig. 1Expression and purification of TGEV GST-N protein. TGEV N protein was expressed in *E. coli*, and lysates were resolved and purified by 12% PAGE. Proteins were visualized by PhastGel Blue R staining (lanes 1--4) or N protein was detected by western blotting with a GST mAb (lanes 5 and 6). Lane 1, protein molecular weight marker; lane 2, induced culture of *E. coli* transformed with pGEX-TGEV-N; lanes 4 and 5, recombinant N protein purified by GST agarose; lanes 3 and 6, induced culture of *E. coli* transformed with pGEX-6p-1.

3.2. EF1A interacting with N protein *in vitro* {#sec0070}
-----------------------------------------------

The expressed GST-N protein immobilized on GST-agarose beads was used as a bait to pull down cellular proteins of ST cells that form a complex with N protein. GST protein was used as control to eliminate non-specifically binding proteins. Cellular proteins immobilized on GST-agarose beads in GST pull-down assay were examined with specific antibodies to EF1A ([Fig. 2](#fig0010){ref-type="fig"} ). From the GST pull-down results, we can see that the EF1A protein was found in GST-N protein immobilized beads but not in GST protein immobilized beads.Fig. 2Cellular EF1A interacts with N protein of TGEV *in vitro*. EF1A binding to GST-N agarose or to GST protein were resolved by Wb. PM, protein marker. GST-N and GST proteins were visualized using mAb to GST; Cellular EF1A of ST cells was visualized using pAb to EF1A.

3.3. Cellular EF1A interacts with N protein of TGEV in virus-infected cells {#sec0075}
---------------------------------------------------------------------------

The immunoprecipitation assay was utilized to elucidate further whether TGEV N protein interacted with cellular EF1A in TGEV-infected ST cells. From the immunoprecipitation results ([Fig. 3](#fig0015){ref-type="fig"} ), we can see that the N protein of TGEV was precipitated by the antibody to cellular EF1A in TGEV-infected ST cells but not in mock-infected ST cells. Furthermore, the same results were obtained with TGEV infectious strain or with TGEV attenuated strain ([Fig. 3](#fig0015){ref-type="fig"}). These results demonstrated that the cellular EF1A interacted with the N protein of TGEV.Fig. 3Cellular EF1A interacts with N protein of TGEV in virus-infected cells. N protein of TGEV was precipitated by mAb to cellular EF1A in TGEV-infected ST cells but not in mock-infected ST cells. T+ and T− represent the TGEV infected and uninfected ST cells, respectively. T + 1 represent the TGEV infectious H strain. T + 2 represent the TGEV attenuated H strain.

3.4. Co-localization of EF1A with N protein in TGEV infected cells {#sec0080}
------------------------------------------------------------------

The subcellular localization of EF1A was investigated in TGEV-infected ST cells using indirect immunofluorescence confocal microscopy. The results indicated that the subcellular localization of EF1A was distributed in the cytoplasm after TGEV infection ([Fig. 4](#fig0020){ref-type="fig"} ). Furthermore, the red fluorescence of the TRITC-labeled goat anti-rabbit IgG binding with cellular EF1A was covered with the green fluorescence of the FITC-labeled goat anti-mouse IgG binding with N protein of TGEV. The evidence indicated that cellular EF1A was co-localized with N protein of TGEV within the ST cells during infection.Fig. 4Localization of cellular EF1A and N protein of TGEV. Cells were infected with TGEV. Virus assembly sites were located using antibodies specific for the N protein (green). EF1A was visualized using antibodies specific for EF1A (red). The nucleus was stained with DAPI (blue). The triple-stained cells were observed by Leica TCS SP5 laser confocal microscopy. Bars, 10 μm.

3.5. Knockdown of EF1A impairs TGEV replication in host cell {#sec0085}
------------------------------------------------------------

To further investigate the role of EF1A in TGEV virus replication, EF1A protein of ST cells was inhibited using siRNA. TGEV attenuated virus was used for siRNA analysis. The transfected cells expressed lower protein levels of EF1A when compared with the control siRNA-transfected cells ([Fig. 5](#fig0025){ref-type="fig"}A and B). ST cells were infected with TGEV for another 8 h or 24 h after transfection with siRNA at an MOI of 1. The viral RNA was measured by quantative real-time RT-PCR and the N protein of TGEV was measured by western blotting. TGEV infection was greatly reduced in the EF1A-knockdown cells, as shown by a reduction in viral N protein expression ([Fig. 5](#fig0025){ref-type="fig"}A and B). To demonstrate the involvement of EF1A on TGEV replication, we quantified the amounts of cell-associated virus and virus releasing in culture supernatant at 8 h and 24 h after inoculation. Virus titer assay were performed three times for each condition and were performed using the Student\'s *t*-test. At 8 h inoculation, the specific numerical TCID~50~ of supernatant virus in control siRNA group was 10^3.1^/mL and the EF1A siRNA group was 10^2.3^/mL. The specific numerical TCID~50~ of cell-associated virus in control siRNA group was 10^3.9^/mL and the EF1A siRNA group was 10^3.2^/mL. At 24 h inoculation, the specific numerical TCID~50~ of supernatant virus in control siRNA group was 10^4.6^/mL and the EF1A siRNA group was 10^3.7^/mL. The specific numerical TCID~50~ of cell-associated virus in control siRNA group was 10^4.5^/mL and the EF1A siRNA group was 10^3.6^/mL. [Fig. 5](#fig0025){ref-type="fig"}C shows that knock-down of EF1A resulted in significant reduction of cell-associated virus, which reflected viral replication.Fig. 5Gene silencing of EF1A reduced TGEV replication in ST cells. EF1A-knockdown cells and negative control knockdown cells were adsorbed with TGEV (MOI = 1) at 37 °C for 1 h. The cells were washed and further incubated with TGEV. The cell lysates were harvested for western blotting with antibodies against EF1A, TGEV N protein and GAPDH, as indicated (A). The averaged densitometric intensity of EF1A and N protein in immunoblot analysis, with GAPDH as a loading control (B). The culture supernatants of cells and the virus-associated cells infected with TGEV for 8 h and 24 h were collected for viral titration (C). The virus titers shown here are the averages and standard deviations of three independent samples. \**p* \< 0.05.

4. Discussion {#sec0090}
=============

N protein of CoVs facilitates template switching and is required for efficient transcription ([@bib0140], [@bib0165], [@bib0190]). In addition, N protein displays pleiotropic effect when expressed in host cells, such as induction of apoptosis or cell-cycle arrest ([@bib0080], [@bib0160]). Some of the functional outcomes that result from N gene expression in host cells are due to direct or indirect interaction between N protein and cellular proteins. Studying the interaction of cellular protein with N protein will provide new information for understanding the mechanism of TGEV infection.

Results from previous study demonstrate that EF1A can anchor mRNA, suggesting that EF1A is involved in sorting and regulating the expression of specific cellular mRNAs ([@bib0015]). EF1 complex is composed of four different subunits, alpha, beta, gamma, and delta (2:1:1:1) in mammalian cells ([@bib0025]). In TGEV infected cells, EF1A may interact with N protein of TGEV that bind to TGEV RNA in a similar manner. Instead of an enzymatic activity, EF1A may provide protein--RNA and protein--protein interactions that promote the assembly of TGEV replication complexes. In this study, the results demonstrate that EF1A can interact with N protein of TGEV. It is possible that EF1A is involved in targeting TGEV N onto intracellular membranes that provide a microenvironment for the efficient replication of the viral RNA. From [Fig. 3](#fig0015){ref-type="fig"}, we can see that the attenuated strain of TGEV N protein appears to be pulled down much more with EF1A than the wild type N protein in. The reason maybe that attenuated TGEV virus was better to adapt ST cells than infectious TGEV (data not shown). We assumed that the interaction of EF1A and N protein maybe play a role in cell culture adaptation.

The intrinsic characteristics of EF1A make it a suitable host protein for RNA virus replication. Results in this study support a role for EF1A in the replication of CoVs. In host cells, EF1A is found in high concentrations, approximately 1% of the total protein in animal cells ([@bib0045]) and 5% in plant cells ([@bib0020]). For viral replication, the abundance of EF1A would make it unnecessary to compete with cellular processes. CoVs replicate in many hosts ([@bib0065]). It is likely that host factors selected for virus replication would be both structurally and functionally conserved across different species. EF1A affords an excellent model system for the further analysis of host protein and virus interactions.

EF1A play an important role in some virus infection. Several viral proteins have been observed to bind to EF1A. The NS5A protein of bovine viral diarrhea virus (BVDV) interacts with EF1A, which may play a role in the replication of BVDV ([@bib0090]). The nucleocapsid protein of SARS-CoV interacted with EF1A and inhibited cell proliferation ([@bib0185]). The RNA-dependent RNA polymerase of Turnip mosaic virus (TuMv) interacts with EF1A in virus-induced vesicles ([@bib0170]). RNA polymerase of vesicular stomatitis virus (VSV) specifically associates with EF1A ([@bib0050]). Gag polyprotein of human immunodeficiency virus type 1 (HIV-1) interacts with EF1A requires tRNA, and EF1A may contribute to tRNA incorporation into HIV-1 virions ([@bib0040]). Studying the mechanism of EF1A and N protein of TGEV will help to understand the pathogenesis of CoVs.

5. Conclusions {#sec0095}
==============

In summary, EF1A interaction with N protein of TGEV was found. The efficiency of TGEV replication depends on the presence of EF1A, which may facilitate virus replication. EF1A may promote viral replication by interaction with N protein. The present study thus provides information that should be useful for underlying mechanism of coronavirus replication.
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